New Mycobacterial Clinic offers integrated care for patients with Non-tuberculous mycobacteria pulmonary disease
A new clinic that offers care for patients with Non-tuberculous mycobacteria pulmonary disease (NTM-PD) is scheduling appointments in the Pulmonary Outpatient Clinic in the Center for Advanced Medicine. The clinic is a joint effort between Washington University physicians Carlos Mejia, MD, assistant professor in the division of infectious diseases; Thomas Bailey, MD, professor of medicine in […]
COVID-19 Vaccine Trials at SLU and WashU Recruit St. Louis Area Residents (Links to an external site)
“Rachel Presti, MD, PHD is the director of Washington University’s Infectious Diseases Clinical Research Unit and principal investigator for the COVID-19 vaccine trials. Presti and Frey are coordinating so the two institutions can lead different vaccine trials.”
Rachel Presti, MD, PhD leads Washington University effort to conduct COVID-19 vaccine trials in collaboration with Saint Louis University
As U.S. scientists ramp up a national effort to evaluate COVID-19 vaccine candidates at clinical trial sites across the country, researchers at Washington University School of Medicine in St. Louis and the Saint Louis University Center for Vaccine Development have been tapped to join the historic effort to find a COVID-19 vaccine that can prevent […]
Rachel Presti, MD, PhD, associate professor and investigator at the IDCRU/ACTU for HPTN 083 says study results are a game changer for HIV prevention
HPTN 083 Study Demonstrates Superiority of Cabotegravir for the Prevention of HIV . Both cabotegravir and oral tenofovir/emtricitabine (TDF/FTC) have high efficacy for pre-exposure prophylaxis (PrEP). Researchers from the HIV Prevention Trials Network (HPTN) announced today that the HPTN 083 clinical trial showed that a pre-exposure prophylaxis (PrEP) regimen containing long-acting cabotegravir (CAB LA) injected […]
In two and a half weeks Jane O’Halloran, MD and Phil Mudd, MD create COVID-19 specimen bank
In early March, just as the pandemic was gaining steam in the St. Louis region, Jane O’Halloran, MD, PhD, an assistant professor of medicine, and Philip Mudd, MD, PhD, assistant professor of emergency medicine, met to discuss the possibility of creating a COVID-19 specimen bank. Two and a half weeks later, they began collecting their […]
Patients with COVID-19 donate specimens to advance research efforts
Philip Mudd, MD, PhD, above, an assistant professor of emergency medicine, and his colleague, Jane O’Halloran, MD, PhD, assistant professor of medicine, infectious diseases specialist, have led efforts to create a repository for storing and managing specimens collected from patients with COVID-19. To date, more than 7,000 samples, including blood, urine and saliva specimens, have […]
COVID-19 survivors needed to donate blood plasma (Links to an external site)
COVID-19 survivors are needed to donate blood plasma. Infectious diseases physicians at Washington University School of Medicine in St. Louis have developed an expanded access program to give blood plasma from COVID-19 survivors to critically ill patients. Infectious diseases physicians at Washington University School of Medicine in St. Louis have developed an expanded access program […]
Clinical trial launches to evaluate antimalarial drugs for COVID-19 treatment (Links to an external site)
Cigna/Express Scripts provided the drugs; open to COVID-19 patients at Barnes-Jewish Hospital Washington University School of Medicine in St. Louis is launching a clinical trial for patients hospitalized with COVID-19 at Barnes-Jewish Hospital. The trial will investigate the effectiveness of different combinations of the antimalarial drugs chloroquine and hydroxychloroquine and the antibiotic azithromycin in treating […]
$3.4 million aids effort to make a better flu vaccine (Links to an external site)
Rachel Presti, MD, PhD and the Infectious Diseases Clinical Research Team collaborate in $3.4 million effort to make a better flu vaccine